OBJECTIVES: We examined socioeconomic disparities in a community-based tobacco dependence treatment program. METHODS: We provided cognitive-behavioral treatment and nicotine patches to 2739 smokers. We examined treatment use, clinical and environmental, and treatment outcome differences by socioeconomic status (SES). We used logistic regressions to model end-of-treatment and 3- and 6-month treatment outcomes. RESULTS: The probability of abstinence 3 months after treatment was 55% greater for the highest-SES than for the lowest-SES (adjusted odds ratio [AOR] = 1.55; 95% confidence interval [CI] = 1.03, 2.33) smokers and increased to 2.5 times greater for the highest-SES than for the lowest-SES smokers 6 months after treatment (AOR = 2.47; 95% CI = 1.62, 3.77). Lower-SES participants received less treatment content and had fewer resources and environmental supports to manage a greater number of clinical and environmental challenges to abstinence. CONCLUSIONS: Targets for enhancing therapeutic approaches for lower socioeconomic groups should include efforts to ensure that lower-SES groups receive more treatment content, strategies to address specific clinical and environmental challenges associated with treatment outcomes for lower-SES smokers (i.e., higher dependence and stress levels and exposure to other smokers), and strategies to provide longer-term support.
OBJECTIVES: We examined socioeconomic disparities in a community-based tobacco dependence treatment program. METHODS: We provided cognitive-behavioral treatment and nicotine patches to 2739 smokers. We examined treatment use, clinical and environmental, and treatment outcome differences by socioeconomic status (SES). We used logistic regressions to model end-of-treatment and 3- and 6-month treatment outcomes. RESULTS: The probability of abstinence 3 months after treatment was 55% greater for the highest-SES than for the lowest-SES (adjusted odds ratio [AOR] = 1.55; 95% confidence interval [CI] = 1.03, 2.33) smokers and increased to 2.5 times greater for the highest-SES than for the lowest-SES smokers 6 months after treatment (AOR = 2.47; 95% CI = 1.62, 3.77). Lower-SESparticipants received less treatment content and had fewer resources and environmental supports to manage a greater number of clinical and environmental challenges to abstinence. CONCLUSIONS: Targets for enhancing therapeutic approaches for lower socioeconomic groups should include efforts to ensure that lower-SES groups receive more treatment content, strategies to address specific clinical and environmental challenges associated with treatment outcomes for lower-SES smokers (i.e., higher dependence and stress levels and exposure to other smokers), and strategies to provide longer-term support.
Authors: Jeff Niederdeppe; Matthew C Farrelly; James Nonnemaker; Kevin C Davis; Lauren Wagner Journal: Soc Sci Med Date: 2011-01-27 Impact factor: 4.634
Authors: Megan E Piper; Jessica W Cook; Tanya R Schlam; Douglas E Jorenby; Stevens S Smith; Daniel M Bolt; Wei-Yin Loh Journal: Nicotine Tob Res Date: 2010-05-03 Impact factor: 4.244
Authors: Jessica L Reid; David Hammond; Christian Boudreau; Geoffrey T Fong; Mohammad Siahpush Journal: Nicotine Tob Res Date: 2010-10 Impact factor: 4.244
Authors: Danielle E McCarthy; Thomas M Piasecki; Douglas E Jorenby; Daniel L Lawrence; Saul Shiffman; Timothy B Baker Journal: Addiction Date: 2010-09-15 Impact factor: 6.526
Authors: Michael S Businelle; Darla E Kendzor; Lorraine R Reitzel; Tracy J Costello; Ludmila Cofta-Woerpel; Yisheng Li; Carlos A Mazas; Jennifer Irvin Vidrine; Paul M Cinciripini; Anthony J Greisinger; David W Wetter Journal: Health Psychol Date: 2010-05 Impact factor: 4.267
Authors: Diana J Burgess; Steven S Fu; Siamak Noorbaloochi; Barbara A Clothier; Jennifer Ricards; Rachel Widome; Michelle van Ryn Journal: Nicotine Tob Res Date: 2009-10-29 Impact factor: 4.244
Authors: A Feinberg; P M Lopez; K Wyka; N Islam; L Seidl; E Drackett; A Mata; J Pinzon; M R Baker; J Lopez; C Trinh-Shevrin; D Shelley; Z Bailey; K A Maybank; L E Thorpe Journal: J Urban Health Date: 2017-08 Impact factor: 3.671
Authors: Sarah Moody-Thomas; Laura Nasuti; Yong Yi; Michael D Celestin; Ronald Horswell; Thomas G Land Journal: Am J Public Health Date: 2015-02-17 Impact factor: 9.308
Authors: Bruce Christiansen; Kevin Reeder; Maureen Hill; Timothy B Baker; Michael C Fiore Journal: J Stud Alcohol Drugs Date: 2012-11 Impact factor: 2.582
Authors: Patricia Medina-Ramírez; Steven K Sutton; Úrsula Martínez; Cathy D Meade; Margaret M Byrne; Karen O Brandon; Lauren R Meltzer; Fiorella M Gonzales; Thomas H Brandon; Vani N Simmons Journal: Contemp Clin Trials Date: 2019-08-29 Impact factor: 2.226